APTA's website is undergoing scheduled maintenance. Some functionality will not be available, and we appreciate your patience.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
CMS has proposed a new pathway that could result in quicker coverage of cutting-edge FDA-approved medical devices.
In this review: Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of "Reasonable and Necessary"(proposed rule)
Proposed Medicare Coverage of Innovative Technology (fact sheet)
Effective date (expected): 60 days after publication of the final rule.
Comment deadline: Nov. 2, 2020
News
APTA-Supported Bill Would Increase Payment Under 2025 Medicare Fee ScheduleOct 29, 2024
In anticipation of the 2025 fee schedule final rule, a new bipartisan bill would change an expected 2.8% cut to a 1.9% increase.
News
CMS Unveils New, High-Priced Restrictions on Access to Medicare, Medicaid DataMar 1, 2024
APTA and researchers across the country oppose the new policy, which could have a chilling effect on needed research.
News
Senators From Both Parties Call for Action on Fee Schedule CutsFeb 28, 2024
Describing health care providers as "at a breaking point," 32 senators urge short- and long-term fixes as the next spending deadline looms.
